Stibatin
C12H20O17Sb2 — CID 16683013
View drug profile → sodium stibogluconateData last refreshed: (MolForge compound catalog, from PubChem)
About Stibatin
Stibatin (PubChem CID 16683013) has the molecular formula C12H20O17Sb2 and a molecular weight of 679.80 g/mol. Its IUPAC name is (4R,5S,6R)-2-[[(4R,5S,6R)-4-carboxy-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxy-2-oxo-1,3,2λ5-dioxastibinan-2-yl]oxy]-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxy-2-oxo-1,3,2λ5-dioxastibinane-4-carboxylic acid.
Molecular Properties
| Compound Name | Stibatin |
|---|---|
| PubChem CID | 16683013 |
| Molecular Formula | C12H20O17Sb2 |
| Molecular Weight | 679.80 g/mol |
| Exact Mass | 677.88 |
| IUPAC Name | (4R,5S,6R)-2-[[(4R,5S,6R)-4-carboxy-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxy-2-oxo-1,3,2λ5-dioxastibinan-2-yl]oxy]-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxy-2-oxo-1,3,2λ5-dioxastibinane-4-carboxylic acid |
| SMILES | O=C(O)[C@@H]1O[Sb](=O)(O[Sb]2(=O)O[C@H]([C@H](O)CO)[C@H](O)[C@H](C(=O)O)O2)O[C@H]([C@H](O)CO)[C@@H]1O |
| InChI | InChI=1S/2C6H10O7.3O.2Sb/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;;;;;/h2*2-5,7-8,10H,1H2,(H,12,13);;;;;/q2*-2;;;;2*+2/t2*2-,3-,4+,5-;;;;;/m11...../s1 |
| InChIKey | PFOYFBYIHCVQGB-XCCFGPONSA-N |
| XLogP | -6.10 |
| TPSA | 276.27 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 679.80 |
| LogP ≤ 5 | -6.10 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Related Compounds
Frequently Asked Questions
Browse: Molecules: S · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 16683013 — identifiers, structure, computed properties (public domain)
- DrugCentral drug card 4020 — approved-drug record (CC BY-SA 4.0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.